* Ces horaires sont donnés à titre indicatif.
Contact: Christine DELPRAT
Phone: +33 4 72 68 19 54
e-mail: christine.delprat@univ-lyon1.fr
Keywords: cancerogenesis, oncopathogens, immunoediting, immunotherapy, cancer vaccines
Aims of “Immunology & cancer”:
Using the knowledge of the students in immunology, immunopathology and infectiology, this unit is developing the concepts issued from fundamental research and leading to clinical and pharmaceutical applications in cancerology.
1.Overview of the multi-hits multi-steps and immunoediting in cancerogenesis.
2. Interactions between malignant tumors and the immune system: cancer immunogenicity, immune activation versus suppression by tumor environment
3. Mechanisms of pathogen-induced oncogenesis
4. Cancers of the immune system and consequences
5. Preventive and therapeutic anti-tumor vaccinology
6. Protection of immune-suppressed patients against secondary oncogenesis
Speakers:
Teaching Staff Immunology, oncology from University Claude Bernard Lyon 1.
Conferences concerning new research development in onco-immunology will be organized. Speakers will be invited based on their excellence. Participation of the CNRS-CRCL Associated Partner.
Learning outcomes:
How to analyse, understand and manipulate interactions between tumor cells and the immune system to overcome the cancer progression.
Updated on April 9, 2019.
Type | Libellé | Nature | Coef. | ||
---|---|---|---|---|---|
CT | Contrôle Terminal | CT : Immuno & Cancer | Ecrit session 1 / Ecrit session 2 | 1.5 | |
CC | Contrôle Continu | CC : Immuno & Cancer | Contrôle Continu | 1.5 |